Home · Peptides · Pielotax
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Pielotax

THE KIDNEY RESTORER

A-9 Kidney Peptide Bioregulator

Pielotax is a kidney-derived peptide bioregulator designed to support nephron function, reduce kidney inflammation, and reverse early fibrosis. It works by modulating gene expression in tubular and mesangial cells, enhancing filtration capacity, and supporting hormonal outputs like erythropoietin. Valuable for maintaining kidney health with aging or after nephrotoxic insults.

Pielotax
Pielotax
Pielotax

Pielotax Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

May 8, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Pielotax

◆

Is Pielotax FDA approved?

No. This profile records Pielotax as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Pielotax?

Dose: 30 mg daily orally (with food).

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Pielotax guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Chromatin Remodeling

Increases histone acetylation in kidney cells

Anti-Inflammatory

Suppresses NF-κB to reduce kidney inflammation

Anti-Fibrotic

Inhibits TGF-β to prevent kidney scarring

Erythropoietin Support

Helps maintain healthy EPO production

Those with declining kidney function
People who've taken nephrotoxic medications
Anyone with chronic kidney inflammation
Those with family history of kidney disease
People wanting to protect kidney health with aging

Pielotax Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.